Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14

Deprecated: Function jetpack_form_register_pattern is deprecated since version jetpack-13.4! Use Automattic\Jetpack\Forms\ContactForm\Util::register_pattern instead. in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 6078
Genetic Testing Brand Progenesis Enters the Indian Market - The Pharma Times | Pharma & Health Care News Portal
Latest

Genetic Testing Brand Progenesis Enters the Indian Market

New Delhi, December 12,  2023 :  Progenesis, a globally renowned genetic testing brand based in the USA, has officially stepped into the Indian market with its first Genetic Laboratory in New Delhi and an AI & Bioinformatics Data Centre in Chennai.

The launch event, held today, witnessed the presence of prominent health experts, practitioners, and researchers from across the country, marking a significant milestone for Progenesis.

Progenesis has earned international acclaim for its groundbreaking genetic testing solutions, particularly in the field of In Vitro Fertilisation (IVF) treatment. The brand’s commitment to advancing reproductive genetics in India is underscored by its introduction of cutting-edge technology, unparalleled accuracy, and a dedication to customer-centric services.

Dr. Nabil Arrach, Founder & CEO, Progenesis, expressed his enthusiasm at the launch event, stating, “We are thrilled to bring Progenesis to India, a land of immense opportunity and possibilities. While our first laboratory has been established in Delhi, our goal is to establish a diverse market presence, reaching Tier 2 and 3 markets across the country.”

Progenesis, a tech-strong lab testing brand, aims to raise awareness about genetic diseases and disorders, leveraging advanced technologies, including Artificial Intelligence, to provide non-invasive and precise results to the Indian market.

In a move towards digital innovation, Progenesis has introduced the first online medical portal for Preimplantation Genetic Testing, streamlining the testing process for convenience and accessibility.

Addressing the opportunities in the Indian market, the experts discussed the vast potential in the Indian market for genetic testing, especially in the realm of reproductive health.

“The brand aims to collaborate with local healthcare providers, fertility clinics, and medical practitioners to expand its footprint and make advanced genetic testing solutions more accessible to a wider audience,” said Dr. Nabil Arrach.

The Indian market is witnessing a growing demand for innovative and reliable genetic testing services, and Progenesis is poised to address this need with its state-of-the-art facilities and expertise. The brand envisions playing a pivotal role in advancing the understanding and treatment of genetic disorders, contributing to improved outcomes in assisted reproductive technologies.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

India’s First Lady Surgeon Trained in Robotic Breast Surgery Performs Karnataka’s 1st Robotic Nipple Sparing Mastectomy

Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…

1 day ago

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

1 week ago

Milestone set in Indian Medical History – SSI Mantra Surgical Robotic System Performs the First-Ever Successful Surgery on One-Year-Old Infant

SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…

1 week ago

Manipal Hospital Ghaziabad organises Fire Safety Training to Enhance Emergency Response

Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…

2 weeks ago

Professor Dr Robert Zeiser receives DKMS Mechtild Harf Science Award 2024

DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…

3 weeks ago

Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…

3 weeks ago